IP Library › Granted Patent US 11,083,747
Granted Patent B2
US 11,083,747 · App. 17/061,321 · Granted Aug 10, 2021

Compositions of nitrates and methods of use thereof

Inventors: Jon Lundberg (Djursholm, SE); Eddie Weitzberg (Stockholm, SE)
A61K33/00A23L2/02A23L2/52A23L33/105A23L33/135A23L33/16A61K9/0056A61K9/0095A61K9/08A61K31/05A61K31/198A61K31/375A61K33/14A61K33/30A61K36/185A61K36/21A61K45/06A61P9/12A23V2002/00C01D9/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,083,747
App. No.
17/061,321
Granted
Aug 10, 2021
Kind
B2
Abstract

Inorganic anions nitrate and nitrite influence metabolic rate and glucose homeostasis. Infusion of nitrite iv caused an acute drop in resting energy expenditure (oxygen consumption) and nitrate, when given perorally, caused a reduction in oxygen consumption during exercise and a depression of the increase in blood glucose observed after an oral glucose tolerance test. The doses of nitrate and nitrite did not cause any detectable change in methemoglobin levels of blood. Also, nitrate and nitrite did not alter lactate levels in blood. This discovery provides useful treatments to regulate the energy expenditure and glucose homeostasis of a mammal by administration of inorganic nitrite and/or nitrate.

Claims (7)

1. A method of decreasing systolic blood pressure, the method comprising administering inorganic nitrate (NO 3 − ) to an adult human subject.

2. The method of claim 1 , whereby administration of the inorganic nitrate (NO 3 − ) reduces diastolic blood pressure of the adult human subject.

3. The method of claim 1 , wherein the inorganic nitrate (NO 3 − ) is administered in a composition in the form of a liquid, a paste, a gel, a bar, a cake, a powder, a granulate, an effervescent tablet, a chewing gum, a tablet, a capsule, a lozenge, a fast melting tablet or wafer, a sublingual tablet, or a spray.

4. The method of claim 1 , wherein 0.1 mmol inorganic nitrate (NO 3 − ) is administered per kg body weight of the adult human subject.

5. The method of claim 1 , wherein the inorganic nitrate (NO 3 − ) is administered in a composition consisting of the inorganic nitrate (NO 3 − ) and at least one additive.

6. The method of claim 5 , wherein the composition is a nutritional supplement.

7. The method of claim 5 , wherein the inorganic nitrate (NO 3 − ) is provided from a natural nitrate source.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2020
From: LUNDBERG, JON; WEITZBERG, EDDIE
To: HEARTBEET LTD
Reel/Frame 053953/0982 →
Priority Claims (2)
SE 0700520-0 · Feb 26, 2007 · national
SE 0700729-0 · Mar 22, 2007 · national
Continuity (6)
Continuation 15966508 · Apr 30, 2018
Continuation In Part 14830937 · Aug 20, 2015
Continuation 12528798
Continuation In Part 12528794
Provisional Application 60919709 · Mar 22, 2007
Related Publication 20210038639A1 · Feb 11, 2021
Cited By (2)
US 12,544,399 US 12,576,106